Week 1 HW: Principles and Practices

Class Assignment – Ethics & Governance

Biological Engineering Application

Genetic medicine in Ecuador currently has an important gap because it is mostly based on data from foreign populations. This leads to a high number of Variants of Uncertain Significance (VUS) and errors in local pharmacogenomics, since these tests do not fully recognize Ecuador’s unique genetic diversity. To address this problem, the proposal is BioPrecisión-EC, a diagnostic platform that uses targeted gene panels with Next Generation Sequencing (NGS). These panels are optimized with higher read depth in markers linked to local ancestry, in order to produce results that are truly useful for clinical decision-making.

Ethical Considerations

First, do no harm, which means ensuring that genetic test results are accurate and reliable. This helps avoid wrong diagnoses that could cause unnecessary fear, rushed medical decisions, or inappropriate treatments. It also includes the correct use of genetic information to adjust treatments and medication doses safely for each person.

Second, genetic data security, since genetic information is unique, permanent, and highly sensitive. Acting ethically requires strong digital protection systems to prevent misuse, data theft, or discrimination in areas such as employment or social life.

Finally, the principle of equity, which aims to prevent this technology from benefiting only urban or wealthy populations, and instead promote fair and affordable access for rural communities and historically underserved groups.

Governance Actions

Action 1: Population Validation Filter (Technical Regulation)

Purpose:
At present, genetic tests are sold without proving whether they work well for Ecuadorian populations. This action proposes that ARCSA require each gene panel to demonstrate its effectiveness using local ancestry data before it is approved for sale.

Design:
ARCSA would work together with universities, such as USFQ or SOLCA, to audit the results provided by companies. If a panel does not properly identify variants common in the local population, it would not be authorized for use.

Assumptions:
It is assumed that international companies will be willing to adapt their products in order to keep access to the Ecuadorian market, and that local universities have the technical capacity to support this process.

Risks:
If the requirements are too strict, some companies may decide not to operate in the country. If successful, Ecuador could become a regional reference in population-adapted medicine.

Action 2: Zero Trust Digital Shield (Technical Strategy)

Purpose:
Genetic data are often stored in cloud systems that can be vulnerable to cyberattacks. This action proposes that SENESCYT require laboratories to use a Zero Trust digital security model.

Design:
Access to genetic databases would require strict verification at every step, similar to banking applications. Any unauthorized access attempt would automatically trigger an alert to a national authority.

Assumptions:
It is assumed that private laboratories will accept the higher cost of this system in exchange for an official “Secure Laboratory” certification.

Risks:
A centralized database could become a more attractive target for hackers. If successful, this approach would mean that Ecuadorian genetic data are protected as part of national security infrastructure.

Action 3: Intercultural Consent Program (Community-Based Norm)

Purpose:
This action aims to replace cold legal consent forms with real dialogue. It proposes that Ethics Committees include mediators who speak local languages, such as Kichwa or Shuar.

Design:
Before collecting a sample, the physician explains in simple language how the data will be used and allows the patient to decide whether they want to receive information about secondary findings.

Assumptions:
Communities will trust science more if their language is respected and if they feel ownership over their genetic information.

Risks:
If communication is not clear, fear or stigma could arise. Success would lead to a more human and community-centered science.

Governance Action Scoring

(1 = best performance, 3 = lowest performance, N/A = not applicable)

Comparative Evaluation

When comparing the three governance actions, it becomes clear that no single option solves all ethical concerns on its own. Option 1 is very effective in reducing diagnostic errors and improving result reliability, although it may slow down adoption due to regulation. Option 2 strongly protects genetic data and allows fast responses to security incidents, but it is more expensive and complex to implement. Option 3 stands out for being easier to apply, promoting fairness, and helping communities trust the technology, even though it has a more limited direct impact on laboratory safety.

Governance Option I Would Prioritize

Based on the analysis of risks and benefits, I believe that the best approach for Ecuador is a combined model that prioritizes population validation of gene panels together with an intercultural consent approach, while leaving more advanced digital security systems as a goal to be developed over time. This combination addresses the lack of precision in genetic tests not designed for local diversity and the historical lack of trust that some communities have toward science.

This recommendation is mainly directed to the Ministry of Public Health and ARCSA. Although this approach may slow down some processes, this cost is acceptable if it helps prevent incorrect diagnoses or harm to patients. For this reason, it is important for the State to invest in professional training and community dialogue so that precision medicine becomes a responsible and locally grounded tool.